RE:This stock is about to enter the 20s... Where is management?Echo, echo, echo....The market for CBG is probably saturated and the demand is not there yet. Synthetic THC is dumb considering the abundance of THC in the plant. The analyst(s) covering Willow seem to be long gone and it definately feels that remaining shareholders are bag holders. On the plus side, the whole Cannabis related space is manipulated by shorts and if there is catalyst in the coming months, Willow should reverse course. Until then, forget about it. InMed Pharma got hit hard too. They are selling CBC and CBT and who knows what the demand is there. Apparently THCV is in high demand so you'd think some comoany will start to make that.